Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
New Platform Enables Ultra-Detailed Imaging of Human Brain Tissue

New Platform Enables Ultra-Detailed Imaging of Human Brain Tissue

Innovative ssREAD Database Provides Rich Alzheimer's Disease RNA-Seq Resources for Researchers

Innovative ssREAD Database Provides Rich Alzheimer's Disease RNA-Seq Resources for Researchers

Super-Cooled Brain Cell Molecules Shed Light on Epilepsy Drug Action

Super-Cooled Brain Cell Molecules Shed Light on Epilepsy Drug Action

Astrocyte Receptor Effects Differ Dramatically Between Sexes

Astrocyte Receptor Effects Differ Dramatically Between Sexes

Modifying Cellular Interactions Near Amyloid Plaques May Offer New Alzheimer's Treatments

Modifying Cellular Interactions Near Amyloid Plaques May Offer New Alzheimer's Treatments

Sonification Reveals Hidden Patterns in Protein Folding Dynamics

Sonification Reveals Hidden Patterns in Protein Folding Dynamics

Glutamate tRNA Fragments Play Key Role in Brain Aging and Alzheimer's Disease

Glutamate tRNA Fragments Play Key Role in Brain Aging and Alzheimer's Disease

UCLA Study Reveals Novel Mechanism for Memory Formation During Sleep

UCLA Study Reveals Novel Mechanism for Memory Formation During Sleep

Epigenomic Analysis Reveals Potential Treatment Avenues for ALS

Epigenomic Analysis Reveals Potential Treatment Avenues for ALS

Using State-of-the Art Imaging to Understand Lipid Dysfunction in Alzheimer's

Using State-of-the Art Imaging to Understand Lipid Dysfunction in Alzheimer's

Unveiling Cannabinoid’s Potential for Treating Age-Related Brain Degeneration

Unveiling Cannabinoid’s Potential for Treating Age-Related Brain Degeneration

Newly discovered mechanism identified in the initial stages of Alzheimer's disease

Newly discovered mechanism identified in the initial stages of Alzheimer's disease

Unraveling the Key to Suppressing Protein Misfolding in Neurodegenerative Diseases

Unraveling the Key to Suppressing Protein Misfolding in Neurodegenerative Diseases

Unveiling Mechanisms to Block Tau Aggregation

Unveiling Mechanisms to Block Tau Aggregation

New Model Captures Multiple Factors Driving Alpha-Synuclein Aggregation

New Model Captures Multiple Factors Driving Alpha-Synuclein Aggregation

Study Reveals Structure of Two Nucleic Acid-Degrading Enzymes

Study Reveals Structure of Two Nucleic Acid-Degrading Enzymes

Study Investigates Links Between Gene Expression and Primate Brain Evolution

Study Investigates Links Between Gene Expression and Primate Brain Evolution

Cryo-EM Imaging Unveils Similar Protein Structures in Alzheimer's and Down Syndrome

Cryo-EM Imaging Unveils Similar Protein Structures in Alzheimer's and Down Syndrome

Scientists Pioneer mRNA Approach to Target Alzheimer's Protein

Scientists Pioneer mRNA Approach to Target Alzheimer's Protein

Unraveling the Role of Gene Length in Aging

Unraveling the Role of Gene Length in Aging

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.